Professional Venture Capital

now available to individual investors

Midwest Values

avoiding Silicon Valley’s inflated valuations

Exceptional Returns

team average annual returns of 28% over the past 30 years

The VCapital Advantage

World-class due diligence and proven instincts combine to bring you institutional quality venture capital opportunities. Reasonable fees and minimums make it easy to diversify your portfolio with potentially game-changing deals. If you’re a savvy investor, you’ll want to look at the details of our current deals.

Midwest focus

Based in Chicago, we know what drives business success in the heartland and beyond.

High-quality deals

We seek opportunities to make a difference to the world and to your bottom line.

Early Stage

Early stage investors, we concentrate on the underserved $500k-$5M range.

Involved

Deep operating experience enables us to guide our funded entrepreneurs to successful outcomes.

Experienced

Our industry connections, expansive network, and 30-year track record gives us access to unique deals.

Selective

We only invest in opportunities that pass our rigorous screening and vetting process.

Invest with VCapital

Take a look below at our current opportunities, recent investments, and just some of the deal opportunities currently in due diligence. We’d be pleased to help you select and invest in the best opportunities for your portfolio.

We offer two options for the management fee.

  • a one-time fee equal to 8% of the undersigned’s capital contribution to the Company.
  • an annual fee equal to 2% per annum of the undersigned’s capital contribution to the Company.

Current Opportunities

http://www.intensitytherapeutics.com | Pharmaceuticals, Biotechnology | Westport, CT

Our team invested $2.4 million in Intensity Therapeutics and raised an additional $1.5 million for the Company. Intensity Therapeutics is pioneering a new field of cancer treatment – in situ vaccination – to eliminate metastatic disease and prevent cancer from recurring.
Learn more

http://simmachines.com | Software as a Service – Machine Learning | Chicago, IL

simMachines is changing the Machine Learning (ML) paradigm with its proprietary similarity-based technology, which is the only ML technology capable of providing transparency to the factors driving the prediction (what is called Predictions with The WHY™) at the speed and scale required for enterprise use.
Learn more

Xaptum Logo
https://www.xaptum.com/ | Network Communications | Chicago, IL

Xaptum is the world’s first hardware security provider for the Internet of Things (IoT). The company’s products help organizations by providing a secure, scalable, agile and robust private network to exchange data between devices and the cloud.
Learn more

Recent Investments

FUNDED - CLOSED
https://www.padcaster.com/ | Media & Technology | Chicago, IL

The all-in-one tool for iPads and cell phones which turns them into your own personal recording and video device. This company already has significant revenue and is sold world-wide.
Learn more

FUNDED - CLOSED
https://www.camrasvision.com/ | Medical Device | Research Park Triangle, NC

Camras Vision is developing the next generation of glaucoma treatments with their revolutionary device – The Camras Shunt. This patented device exceeds the ability of current prescription drug therapies and surgical treatments in treating glaucoma.
Learn more

FUNDED - CLOSED
https://getsynap.com | Software as a Service – CRM | Chicago, IL

Synap makes and sells software primarily for account management and customer success teams. Its flagship product is designed specifically for post-sales engagement, helping teams to build, collaborate, and execute on their plans to grow customer relationships.
Learn more

CLASS A SERIES
FUNDED - CLOSED
http://simmachines.com | Software as a Service – Machine Learning | Chicago, IL

simMachines is changing the Machine Learning (ML) paradigm with its proprietary similarity-based technology, which is the only ML technology capable of providing transparency to the factors driving the prediction (what is called Predictions with The WHY™) at the speed and scale required for enterprise use.
Learn more

CLASS A SERIES
FUNDED - CLOSED
http://www.intensitytherapeutics.com | Pharmaceuticals, Biotechnology | Westport, CT

Our team invested $2.4 million in Intensity Therapeutics and raised an additional $1.5 million for the Company. Intensity Therapeutics is pioneering a new field of cancer treatment – in situ vaccination – to eliminate metastatic disease and prevent cancer from recurring.
Learn more

ACQUIRED
http://www.cleversafe.com | Data Storage | Chicago, IL

Cleversafe is the marketplace leader in dispersed storage technology for unstructured data in the petabyte-plus range. Our team raised $4.5 million through BVC. The company was purchased by IBM in Oct. 2015 for $1.3 billion.
Learn more

Invest with VCapital

Select and invest in the best opportunities for your portfolio using our online platform.
$25,000 minimum.

Opportunities Currently in Due Diligence

Software-as-a-Service Atlas Space Operations

Atlas is a state-of-the-art satellite command and control company that provides customers with cost-effective cloud-based solutions for communicating with satellites.

Biotech/Pharmaceuticals Anonymous

Creating new medicines to prevent life-threatening allergic reactions to food, particularly peanuts, giving people with food allergy peace of mind and relief from the fear of an accidental exposure.

Medical/Devices Diagnostic Photonics

Diagnostic Photonics is a medical imaging company helping cancer surgeons see the invisible, find missed cancer, and avoid repeat surgery. The company's Foresee™ Imaging System provides the surgeon with a live, microscopic view of the tumor and targets over 2M cancer surgeries annually.

If you're already a VCapital member, we'll let you know when any of these opportunities become active deals. If you're not yet a VCapital member but want to hear about new deals, join now.

Get an in-depth look at
Venture Capital investing

Our Founder and long-time venture capital all-star Len Batterson has been winning for investors for over 30 years. Now, Len, and Board Member, Ken Freeman, share their wisdom and strategies for successful Venture Capital Investing.

Get your free copy

Interested in Becoming a Founding Investor?

For a limited time, you may also join VCapital as a founding investor. You will have priority access to our dealflow, the opportunity to connect with portfolio company management teams, and participate in the proceeds in all successful deals, now and in the future!

Learn More

Get Started

Join other savvy investors to see full deal information, get deal flow updates, or make an investment.